Market Tracker

08/25 5:41am ET

Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.57
Delayed Data
As of Aug 24
 -0.57 / -6.24%
Today’s Change
4.50
Today|||52-Week Range
11.69
+27.53%
Year-to-Date
3 Reasons Inovio Pharmaceuticals Inc. Stock Could Rise
Aug 19 / MotleyFool.com - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Aug 17 / Zacks.com - Paid Partner Content
Better Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation
Aug 11 / MotleyFool.com - Paid Partner Content
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals
Aug 15 / MotleyFool.com - Paid Partner Content
Zika Virus and Today's Stock Market
Aug 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close9.14
Today’s open9.14
Day’s range8.50 - 9.24
Volume1,636,132
Average volume (3 months)1,564,340
Market cap$672.2M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc-0.65-8.00%
ATRAAtara Biotherapeutic...-2.05-9.24%
RTRXRetrophin Inc-0.56-3.30%
EDITEditas Medicine Inc-1.78-8.84%
Data as of 08/24/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts